AMRN News and Press, Amarin Corporation plc From 01/15/24

2024-01-15 03:06:15 ET Summary Sarissa Capital is successfully turning around Amarin, giving it new life and potential for success. Amarin's REDUCE-IT trial proved the cardiovascular benefits of its purified EPA product, Vascepa, leading to its potential for greatness. The imp...

2024-01-10 19:02:43 ET Shares of Amarin (NASDAQ: AMRN) skyrocketed 32.9% on Wednesday after the biopharmaceutical company announced strong preliminary fiscal fourth-quarter results, a new share-repurchase authorization, and encouraging 2024 guidance. In a press release this morn...

2024-01-10 18:40:24 ET Amarin Corporation plc (AMRN) 42nd Annual J.P. Morgan Healthcare Conference January 10, 2024, 04:30 PM ET Company Participants Pat Holt - President & CEO Conference Call Participants Jess Fye - JPMorgan Presentation Je...

2024-01-10 07:25:21 ET More on Amarin Amarin Corporation plc (AMRN) Q3 2023 Earnings Call Transcript Sarissa Capital says Amarin stock undervalued, months after winning proxy contest Amneal Pharma in pact with Strides to launch generic Vascepa Seeking Alpha&#...

-- Reported Unaudited Total Revenues of Between $72 Million - $74 Million in the Fourth Quarter of 2023 -- -- Company Ends 2023 with a Cash Position of $321 Million and Delivered Full-Year Positive Cash Flow of ~$10 Million -- -- 2024 Key Priorities Include Accelerating Revenue ...

DUBLIN, Ireland and BRIDGEWATER, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced its participation in the 42 nd Annual JP Morgan Healthcare Conference. Amarin’s president and chief executive officer, Patrick Holt, is scheduled to present at ...

2023-12-04 16:57:15 ET Sarissa Capital Management on Monday said that it believed Amarin's ( NASDAQ: AMRN ) stock was "significantly undervalued," more than nine months after the activist investor won a proxy fight against the Ireland-based company's board. In March, Sariss...

2023-12-01 13:40:47 ET More on Amarin, Amneal, etc. Amneal Pharmaceuticals, Inc. (AMRX) Q3 2023 Earnings Call Transcript Amneal Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation Amarin Corporation plc (AMRN) Q3 2023 Earnings Call Transcript ...

2023-11-26 10:47:19 ET Summary Soleno Therapeutics has seen a surge in stock value after positive data from Phase III trials of its Diazoxide Choline Extended-Release tablet for Prader-Willi Syndrome. The data showed improvements in body composition and hyperphagia-related behavio...

2023-11-25 16:32:53 ET More on BioCryst Pharmaceuticals, Crinetics Pharmaceuticals, etc. Mirum Pharmaceuticals, Inc. (MIRM) Q3 2023 Earnings Call Transcript BioCryst Pharmaceuticals, Inc. (BCRX) Q3 2023 Earnings Call Transcript Immunocore: First Half Of 2024 IMC-F106...